NEU 0.35% $20.17 neuren pharmaceuticals limited

Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-37

  1. 12,999 Posts.
    lightbulb Created with Sketch. 774
    Mr_Cod: "If trofinetide is approved, it would seem to me that it is almost certain that Acadia would make us an offer."

    Mr_Cod/others: I have thought for some time now that sooner or later Acadia would make an offer! My question: At what pricing (IF at any?) a take-over offer would/will be accepted by NEU ??
    Comments most welcome!

    wasa
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.